Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Buys

Showing results (211-220 of 322) with videos related to

Pageof 33
Sort By:
Breast Cancer Research : BCR|November 30, 2019
Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)Nur Zeinomar, Julia A Knight, Jeanine M Genkinger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.
The Journal of Clinical Investigation|July 23, 2013
Atrial natriuretic peptide is negatively regulated by microRNA-425Pankaj Arora, Connie Wu, Abigail May Khan, et al.
BJU International|May 27, 2018
Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutationsElizabeth K Bancroft, Sibel Saya, Elizabeth C Page, et al.
Breast Cancer Research : BCR|November 5, 2018
Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)John L Hopper, Gillian S Dite, Robert J MacInnis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017Mary B Daly, Robert Pilarski, Michael Berry, et al.
The New England Journal of Medicine|March 20, 2009
Mortality results from a randomized prostate-cancer screening trialGerald L Andriole, E David Crawford, Robert L Grubb, et al.
American Journal of Human Genetics|April 3, 2012
Rare mutations in XRCC2 increase the risk of breast cancerD J Park, F Lesueur, T Nguyen-Dumont, et al.
Journal of the National Cancer Institute|January 10, 2012
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-upGerald L Andriole, E David Crawford, Robert L Grubb, et al.
JAMA Network Open|September 9, 2024
Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models: The BRIDGE Randomized Clinical TrialKimberly A Kaphingst, Wendy K Kohlmann, Rachelle Lorenz Chambers, et al.
Pageof 33

Showing results (211-220 of 322) with videos related to

Sort By:
Pageof 33
Breast Cancer Research : BCR|November 30, 2019
Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)Nur Zeinomar, Julia A Knight, Jeanine M Genkinger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.
The Journal of Clinical Investigation|July 23, 2013
Atrial natriuretic peptide is negatively regulated by microRNA-425Pankaj Arora, Connie Wu, Abigail May Khan, et al.
BJU International|May 27, 2018
Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutationsElizabeth K Bancroft, Sibel Saya, Elizabeth C Page, et al.
Breast Cancer Research : BCR|November 5, 2018
Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)John L Hopper, Gillian S Dite, Robert J MacInnis, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017Mary B Daly, Robert Pilarski, Michael Berry, et al.
The New England Journal of Medicine|March 20, 2009
Mortality results from a randomized prostate-cancer screening trialGerald L Andriole, E David Crawford, Robert L Grubb, et al.
American Journal of Human Genetics|April 3, 2012
Rare mutations in XRCC2 increase the risk of breast cancerD J Park, F Lesueur, T Nguyen-Dumont, et al.
Journal of the National Cancer Institute|January 10, 2012
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-upGerald L Andriole, E David Crawford, Robert L Grubb, et al.
JAMA Network Open|September 9, 2024
Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models: The BRIDGE Randomized Clinical TrialKimberly A Kaphingst, Wendy K Kohlmann, Rachelle Lorenz Chambers, et al.
Pageof 33